Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
new york blog main
9
×
biotech
boston blog main
life sciences
new york top stories
national top stories
boston top stories
san francisco blog main
startups
wisconsin blog main
deals
detroit blog main
detroit top stories
merck
raleigh-durham blog main
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco top stories
wisconsin top stories
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
clinical trials
david schenkein
debate
digital
donald trump
drug price
econmoic impact
What
based
9
×
million
new
medicines
startup
u.s
add
advance
american
best
bio
company
continue
crash
deal
debate
healthcare
industry
kind
medical
nash
people
pharmaceutical
policy
politicians
pressure
research
roundup
scalps
step
trump’s
acquisition
adds
aims
alnylam
ann
approach
arbor
begin
biolinq
Language
unset
Current search:
xconomy.com
×
based
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com
5 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round